Nov
DEC
Jan
21
2014
2015
2016
1 captures
21 Dec 15 - 21 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Featured Articles
The SHIELD Trial: Final Results and Epidemiological and Public Policy Implications
Diabetes: Beyond Just Type 1 and Type 2
Clinical Trial Highlights
IV Exenatide Has the Same Efficacy as Insulin in C ICU Patients, without Inducing Hypoglycemia
Risk of Mortality Increased with Divergence from Glycemic Target
Depression Increases Risk for Mortality in People with T2DM
Long-Term Injection-Free Subcutaneous Delivery of Exenatide via ITCA 650 Improves Compliance and Controls Glycemic Parameters and Weight
Novel Agent Found to Reduce HbA1C in Type 2 Diabetes
Intensive Lifestyle Intervention and Metformin are Cost-Effective for Diabetes Prevention
Intraocular Use of Anti-VEGF Antibody Fragment Improves Vision and Retinal Anatomy in DR
Selected Updates
The Role of Antiplatelet Drugs in Diabetes
Novel Diabetes Treatments: New and Future Developments
Risk of Drug-Induced Dysglycemia Typically Outweighed by Benefits
Insulin Resistance Has Independent Role in Atherogenesis
Is Cardiovascular Screening Appropriate for Diabetic Patients Who are Asymptomatic?
Other Peer-Reviewed Articles
OSA Associated with Diabetes Complications
Insulin Delivery: Special Needs of Adolescents
The LOOK Ahead Trial: Four-Year Outcomes of an Intensive Lifestyle Intervention in Type 2 Diabetes
Pediatric Weight Loss Surgery: Is it Time?
Immunomodulatory Therapy Trials in Type 1 Diabetes
New Biomarkers Needed for Early Diabetic Nephropathy
Back to top
Previous
Next
Search for this keyword